review article | Q7318358 |
scholarly article | Q13442814 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 391-395 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | NIH consensus conference. Treatment of early-stage breast cancer | |
P478 | volume | 265 |
Q36694923 | 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up |
Q55119077 | 99mTc-labeled sodium phytate and stannous chloride injection accurately detects sentinel lymph node in axillary of early stage breast cancer: a randomized, controlled study. |
Q37461037 | A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies |
Q35971024 | A review of current practices in breast conservation surgery in the UK. |
Q72483529 | Adjuvant therapy of breast cancer |
Q35570862 | Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer |
Q37065467 | Analysis of prognostic factors and treatment modality changes in breast cancer: a single institution study in Korea |
Q35565325 | Benefits, risks, and safety of external beam radiation therapy for breast cancer |
Q37337769 | Body image disturbance and surgical decision making in egyptian post menopausal breast cancer patients |
Q34743679 | Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons. |
Q41185258 | Breast cancer prevention and control among the medically underserved |
Q37442431 | Breast cancer recurrence in older women five to ten years after diagnosis |
Q36294851 | Breast cancer surgery: comparing surgical groups and determining individual differences in postoperative sexuality and body change stress |
Q35879504 | Breast cancer treatment of older women in integrated health care settings |
Q33928641 | Breast conservation therapy without capsular contracture in young augmented women using interstitial brachytherapy |
Q24792742 | Breast conserving surgery versus mastectomy: cancer practice by general surgeons in Iran |
Q37288561 | Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation |
Q44517514 | Breast-conserving surgery for breast cancer: Patterns of care in a geographic region and estimation of potential applicability |
Q37194623 | Breast-conserving surgery in Hong Kong Chinese women. |
Q52904927 | Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis. |
Q37185862 | Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes. |
Q71116495 | Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment |
Q36935104 | Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. |
Q73224050 | Comparison of Modified Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiation Therapy in Early Breast Cancer in Japaness Women |
Q37802801 | Comparison of magnetic resonance imaging and multidetector computed tomography for evaluating intraductal tumor extension of breast cancer |
Q37124809 | Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy |
Q33914050 | Conductive interstitial thermal therapy (CITT) inhibits recurrence and metastasis in rabbit VX2 carcinoma model. |
Q40598998 | Conservation surgery for breast cancer: selection criteria and technical considerations |
Q31118195 | Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks |
Q26744320 | Contralateral prophylactic mastectomy: current perspectives |
Q54445587 | Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients. |
Q73223977 | Controversies in the Surgical Management of Operable Breast Cancer |
Q34744477 | Coordination of care for early-stage breast cancer patients |
Q84949042 | Cosmetic outcome and percentage of breast volume excision in oncoplastic breast conserving surgery |
Q37276829 | Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines |
Q37378012 | Current molecular diagnostics of breast cancer and the potential incorporation of microRNA |
Q28235549 | Current status and perspectives of brachytherapy for breast cancer |
Q57822483 | Cutaneous Breast Radiation-associated Angiosarcoma: Anterior Chest Wall Reconstruction Options Following Extra-radical Resection |
Q40464350 | Diagnosis and management of spinal metastases from breast cancer |
Q33303050 | Diffusion of good practices of care and decline of the association with case volume: the example of breast conserving surgery |
Q36935099 | Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer |
Q36741163 | Disparities in breast cancer treatment and survival for women with disabilities |
Q36461748 | Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer |
Q90049544 | Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis |
Q72776924 | Do we really need prognostic factors for breast cancer? |
Q35630084 | ESTIMATING TREATMENT EFFECTS ON HEALTHCARE COSTS UNDER EXOGENEITY: IS THERE A 'MAGIC BULLET'? |
Q30486413 | Early stage breast cancer treatments for younger Medicare beneficiaries with different disabilities |
Q35687611 | Effect of Magnetic Resonance Imaging on Breast Conservation Therapy versus Mastectomy: A Review of the Literature |
Q35753996 | Effect of depression on diagnosis, treatment, and survival of older women with breast cancer |
Q36936078 | Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women |
Q82919131 | Endoscopy-assisted breast-conserving surgery for early breast cancer |
Q40957339 | Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison |
Q37103213 | Evaluation of sentinel lymph node metastasis alone guided by three-dimensional computed tomographic lymphography in video-assisted breast surgery |
Q35684418 | Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: a preliminary study |
Q35820277 | Evaluation of trends in the cost of initial cancer treatment |
Q38575198 | Experience of quadrantectomy with axillary dissection without radiotherapy sustained by serial pathological examination for stage I breast cancer |
Q37276942 | Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer |
Q36918148 | Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study |
Q34096088 | Factors that Affect Patients’ Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients |
Q36166224 | Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer |
Q26471067 | Fraction size in radiation therapy for breast conservation in early breast cancer |
Q73150540 | Frozen-section-guided breast-conserving surgery: implications of diagnosis by frozen section as a guide to determining the extent of resection |
Q73224083 | Growth of Breast Cancer and Limited Surgery |
Q33869347 | Health states of women after conservative surgery and radiation for breast cancer |
Q41198548 | Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey |
Q35687641 | Higher Volume at Time of Breast Conserving Surgery Reduces Re-Excision in DCIS. |
Q64907624 | Histopathological Study on Conservatively Operated Breast Carcinomas. |
Q35789997 | Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis |
Q36457914 | Identifying patients who may be candidates for a clinical trial of salvage accelerated partial breast irradiation after previous whole breast irradiation |
Q36011148 | Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status |
Q36936574 | Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996 |
Q42924780 | Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California |
Q37408456 | Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women |
Q36190472 | Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. |
Q40759280 | Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients |
Q57104967 | Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community |
Q34357224 | Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review |
Q49898559 | Is invasion a necessary step for metastases in breast cancer? |
Q34087413 | Is there shared decision making when the provider makes a recommendation? |
Q34359720 | Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation |
Q42065530 | Lymph node shape in computed tomography imaging as a predictor for axillary lymph node metastasis in patients with breast cancer |
Q35193573 | Managed care market share and primary treatment for cancer |
Q34335769 | Medicare breast surgery fees and treatment received by older women with localized breast cancer |
Q35786537 | Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection |
Q35063788 | Minimising unnecessary mastectomies in a predominantly Chinese community |
Q73224736 | Multicentric Breast Carcinoma: Evaluation of Clinicopathological and Immunohistochemical Characteristics |
Q79356014 | Multidisciplinary approach to the management of breast cancer in Hong Kong |
Q49221038 | No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery |
Q36086033 | Occupational type affects the receipt of breast cancer adjuvant chemotherapy in China |
Q33973237 | Oncoplastic volume replacement techniques according to the excised volume and tumor location in small- to moderate-sized breasts |
Q86682808 | Optimising Breast Conservation Treatment for Multifocal and Multicentric Breast Cancer: A Worthwhile Endeavour? |
Q34023647 | Pathogenesis, prevention, diagnosis and treatment of breast cancer |
Q33921572 | Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy |
Q71309459 | Patient satisfaction with decision-making for breast cancer therapy |
Q36122390 | Patient, hospital, and neighborhood factors associated with treatment of early-stage breast cancer among Asian American women in California |
Q37276850 | Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004 |
Q36910446 | Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. |
Q36310182 | Personalized medicine in breast cancer: a systematic review |
Q40931106 | Physiological aspects of aging. Implications for the treatment of cancer |
Q33345743 | Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer |
Q37733083 | Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy. |
Q37707991 | Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor |
Q41617021 | Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer |
Q33766486 | Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size |
Q35843029 | Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens |
Q39717577 | Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer |
Q73223989 | Preliminary Results of Quadrantectomy and Radiation Therapy for Breast Cancer |
Q37332037 | Preliminary testing of a just-in-time, user-defined values clarification exercise to aid lower literate women in making informed breast cancer treatment decisions |
Q37614687 | Prognostic and predictive factors and genetic analysis of early breast cancer. |
Q34692133 | Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients |
Q38192507 | Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre |
Q36935356 | Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002 |
Q40114744 | Racial disparities in travel time to radiotherapy facilities in the Atlanta metropolitan area |
Q36988934 | Radiation therapy resources and guideline-concordant radiotherapy for early-stage breast cancer patients in an underserved region |
Q49962822 | Re-excision and survival following breast conserving surgery in early stage breast cancer patients: a population-based study. |
Q37369805 | Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence |
Q46808162 | Responding to a Community's Concern: A Comparison of Breast Cancer Characteristics and Initial Treatment in Three Selected North Carolina Counties |
Q89543772 | Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy |
Q40040512 | Rural-urban disparities in use of post-lumpectomy radiation |
Q49589163 | Selection of oncoplastic surgical technique in Asian breast cancer patients |
Q35989711 | Sentinel lymph node mapping for primary breast cancer |
Q33224183 | Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer |
Q44248250 | Should women with node-negative breast cancer receive adjuvant chemotherapy?--Insights from a decision analysis model |
Q83987670 | Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer |
Q37710701 | Socioeconomic disparities in breast cancer treatment among older women |
Q36648949 | Specialisation and breast cancer survival in the screening era |
Q39593619 | Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer |
Q36925795 | Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform |
Q50146461 | Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients |
Q50462823 | Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine. |
Q33654994 | Subareolar versus peritumoral injection for location of the sentinel lymph node |
Q40958871 | Surgical Management of Breast Cancer in 2010-2011 SEER Registries by Hormone and HER2 Receptor Status |
Q35207932 | Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017. |
Q35858307 | Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy |
Q34334787 | Survival after partial breast brachytherapy in elderly patients with nonmetastatic breast cancer |
Q36178333 | Survival implications associated with variation in mastectomy rates for early-staged breast cancer |
Q34641102 | Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer |
Q33560280 | Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer |
Q36611787 | Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer |
Q79998517 | The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain |
Q92109231 | The Influence of Surgical Specialty on Oncoplastic Breast Reconstruction |
Q53594411 | The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients? |
Q99240946 | The case for breast-conservation treatment rates to be a quality metric |
Q34554477 | The role of boost irradiation in the conservative treatment of stage I-II breast cancer |
Q37392224 | The role of high-dose-rate brachytherapy boost in breast-conserving therapy: Long-term results of the Hungarian National Institute of Oncology |
Q81551068 | The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida |
Q35020994 | Treatment variation in patients diagnosed with early stage breast cancer in Alberta from 2002 to 2010: a population-based study |
Q36064878 | Trends in Radical Surgical Treatment Methods for Breast Malignancies in China: A Multicenter 10-Year Retrospective Study |
Q37325069 | Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging |
Q33905044 | Tumor characteristics of breast cancer in predicting axillary lymph node metastasis |
Q37986554 | United States trends in the surgical treatment of primary breast cancer |
Q36327291 | Usefulness of Oncoplastic Volume Replacement Techniques after Breast Conserving Surgery in Small to Moderate-sized Breasts |
Q36903415 | Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer |
Q45100743 | Variation in staging and treatment of local and regional breast cancer in the elderly |
Q40956879 | Variations in breast cancer treatment by patient and provider characteristics |
Q53480005 | Video-assisted breast surgery and sentinel lymph node biopsy guided by three-dimensional computed tomographic lymphography. |
Q53112339 | Video-assisted breast surgery can sample the second and third sentinel nodes to omit axillary node dissection for sentinel-node-positive patients. |
Q34336079 | Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa |
Q33483678 | Why do Asian-American women have lower rates of breast conserving surgery: results of a survey regarding physician perceptions |
Q74529171 | [Improved reproducibility and comfort by standardized postural support in the irradiation of the female breast] |
Q73594944 | p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors |
Search more.